membrane proteins and drug discovery: what is the...
TRANSCRIPT
![Page 1: Membrane proteins and drug discovery: what is the linkhomes.gersteinlab.org/.../Drug_Discovery_Review_Arinami… · Web view[1] Davey, J. (2004) G-Protein-Coupled-Receptors: New](https://reader035.vdocument.in/reader035/viewer/2022070806/5f0499097e708231d40ec2e4/html5/thumbnails/1.jpg)
Drug Discovery Today: Informatics (Computational Drug Discovery)
Computational Analysis of Membrane Proteins: the Largest Type of Drug Targets
Yalini Arinaminpathy*,1, Donald M. Engelman1, Mark B. Gerstein1
Address:
1 Department of Molecular Biophysics and Biochemistry, Yale University, 266 Whitney
Avenue, New Haven, CT 06520-8114, USA
* Corresponding Author:
Dr Yalini Arinaminpathy; E-mail: [email protected]
25 – 30 Word Teaser: The sheer pharmacological importance of membrane proteins
contrasts starkly with their limited number of known structures. Computational tools are
valuable in bridging the gap between their structure, function and mechanism.
Keywords: Membrane Proteins, Molecular Dynamics, KcsA, GPCR, ion channels.
1
1
123456789
10
1112
13
16
17
18
19
2
![Page 2: Membrane proteins and drug discovery: what is the linkhomes.gersteinlab.org/.../Drug_Discovery_Review_Arinami… · Web view[1] Davey, J. (2004) G-Protein-Coupled-Receptors: New](https://reader035.vdocument.in/reader035/viewer/2022070806/5f0499097e708231d40ec2e4/html5/thumbnails/2.jpg)
Drug Discovery Today: Informatics (Computational Drug Discovery)
Abstract
The biological importance of integral membrane proteins, from the level of the
cell to entire organism is highlighted by the profound effects of various genetic
deficiencies in transporters and channels. Given their key roles and significance, it is
therefore necessary to understand their structures and thence mechanisms and regulation,
at the molecular level. Membrane proteins represent approximately 30% of currently
sequenced genomes. Paradoxically, however, at present, > 45,000 crystal structures are
deposited in the protein data bank (PDB), of which only 2% are of membrane proteins.
Interestingly, 971 protein folds are currently known, of which only 5% (49 folds) are of
membrane proteins. The great disparity between our understanding of soluble proteins
and membrane proteins has occurred largely due to the many practical problems of
working with membrane proteins, specifically difficulties in expression, purification and
crystallization. Thus, technological developments have been increasingly utilized in order
to make crucial advances in understanding membrane protein structure and function.
2
3
20
21
22
23
24
25
26
27
28
29
30
31
32
33
4
![Page 3: Membrane proteins and drug discovery: what is the linkhomes.gersteinlab.org/.../Drug_Discovery_Review_Arinami… · Web view[1] Davey, J. (2004) G-Protein-Coupled-Receptors: New](https://reader035.vdocument.in/reader035/viewer/2022070806/5f0499097e708231d40ec2e4/html5/thumbnails/3.jpg)
Drug Discovery Today: Informatics (Computational Drug Discovery)
1.1 Introduction
Integral membrane proteins play essential roles in numerous physiological
functions, such as molecular recognition, energy transduction and ion regulation. Despite
the experimental challenges of studying these proteins, they are critical to understand
since they represent more than 60% of drug targets [1], [2]. For example, G-protein
coupled receptors (GPCRs), a class of membrane proteins, are intensively studied using
computational resources since the malfunction of these receptors results in serious
disorders such as hypertension, congestive heart failure, stroke and cancer. On a similar
scale, genetic disorders of ion channels result in ‘channelopathies’ such as cystic fibrosis,
Bartter syndrome and paralysis. Therefore, ongoing technological advances are exploited
to study membrane proteins, in order to improve or develop novel pharmacological drug
targets.
The availability of complete or partial genome sequences for a number of
organisms from a number of domains including the eubacterial, archaean and eukaryotic
domains now makes possible much more detailed studies of membrane protein topology.
Compounded by their genomic abundance, the use of computational tools in this field is
essential and timely. In combination with the advancement of simulation techniques, the
advent of structural genomics has spurred the membrane protein field to consider high-
throughput methods, which can help redress the disparity between soluble proteins and
membrane proteins. Indeed, numerous bioinformatics and proteomic analyses (e.g.[3],
[4], [5], [6], [7]) have been carried out to examine membrane protein architecture and
3
5
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
6
![Page 4: Membrane proteins and drug discovery: what is the linkhomes.gersteinlab.org/.../Drug_Discovery_Review_Arinami… · Web view[1] Davey, J. (2004) G-Protein-Coupled-Receptors: New](https://reader035.vdocument.in/reader035/viewer/2022070806/5f0499097e708231d40ec2e4/html5/thumbnails/4.jpg)
Drug Discovery Today: Informatics (Computational Drug Discovery)
even to closely analyze detailed stabilizing and mediating interactions between
transmembrane helices in membrane proteins.
Membrane proteins are, in many respects, easier to investigate computationally
than experimentally, due to the uniformity of their structure and interactions [8], [9]. The
high propensity to form secondary structures reduces the number of degrees of freedom,
which determine the protein’s fold, and hence lowers the complexity of predicting the
structures of these proteins. Computational techniques represent key methods for relating
the few static experimental membrane protein structures to dynamic biological systems,
thereby yielding maximum benefit from the limited structural and mechanistic
information available. The computational techniques employed in the biological arena to
explore membrane proteins are dizzyingly vast, thus in this review, we will focus on one
intensively utilized technique: MD simulations.
1.2 Membrane Protein Structure
Membrane proteins are essentially divided into two main classes: some contain a
significant portion of their mass within the interior of the membrane (intrinsic or integral
membrane protein (IMP)) while other proteins are only associated to the membrane
surface (extrinsic or peripheral proteins). For IMPs, two common structural motifs have
been observed for the transmembrane (TM) domains of membrane proteins: (1) α-helical
or (2) a β-sheet topology [10]. These two folds [Figure 1] are the simplest solutions to
satisfying the hydrogen bonding potential of the polypeptide backbone amide groups
within the lipid bilayer. The majority of IMPs display α-helical transmembrane segments
4
7
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
8
![Page 5: Membrane proteins and drug discovery: what is the linkhomes.gersteinlab.org/.../Drug_Discovery_Review_Arinami… · Web view[1] Davey, J. (2004) G-Protein-Coupled-Receptors: New](https://reader035.vdocument.in/reader035/viewer/2022070806/5f0499097e708231d40ec2e4/html5/thumbnails/5.jpg)
Drug Discovery Today: Informatics (Computational Drug Discovery)
and can be further divided into two types: bitopic (those which traverse the lipid bilayer
with a single α-helix) and polytopic (an α-helical bundle).
Membrane proteins that are α-helical typically form well-packed bundles as, for example,
found in bacteriorhodopsin, photosynthetic reaction centers and cytochrome C oxidase.
Formation of β-sheets is seen in bacterial outer membrane proteins (e.g. OmpA [11] and
FecA [12]), which span the membrane as β-barrels.
1.3 Experimental structure determination
The disparity between our knowledge of soluble proteins and membrane proteins
is largely due to the practical difficulties involved in expressing and crystallizing the
latter [13]. Their inherent membrane-bound nature makes structure determination a
particular challenge, and thus requires special treatment. This is particularly true for α-
helical membrane proteins as they tend to be hydrophobic and are therefore difficult to
unfold and refold in vitro. β-barrel proteins, on the other hand, are more hydrophilic and
amenable to the traditional methods of denaturation and refolding into detergents, or
directly into lipids [14], [15].
Three main bottlenecks exist with obtaining structural information of membrane
proteins. Firstly, it is difficult to obtain the protein of interest since membrane proteins
5
9
77
78
79
80
81
82
83848586878889909192939495
96
97
98
99
100
101
102
103
104
105
10
![Page 6: Membrane proteins and drug discovery: what is the linkhomes.gersteinlab.org/.../Drug_Discovery_Review_Arinami… · Web view[1] Davey, J. (2004) G-Protein-Coupled-Receptors: New](https://reader035.vdocument.in/reader035/viewer/2022070806/5f0499097e708231d40ec2e4/html5/thumbnails/6.jpg)
Drug Discovery Today: Informatics (Computational Drug Discovery)
are usually only present in the cell at low concentrations. Overexpression is therefore a
necessity for the majority of membrane proteins that cannot be readily obtained in
sufficient amounts from their native environments [16]. Many different expression
systems are used though each have their drawbacks, including low yield (often due to
toxicity), heterogeneous post-translational modification, low stability and partial
proteolysis [13]. The majority of membrane protein crystal structures result from proteins
that naturally occur at high concentrations or have been overexpressed in a homologous
system. Secondly, membrane proteins are naturally embedded in a heterogeneous
dynamic environment of the mosaic lipid bilayer [Figure 2] and it is impossible to use
high-resolution experimental techniques in their native environment.
The proteins therefore need to be extracted from the native membrane and studied in
detergent or lipid environment in vitro, which leads to difficulties in sample preparation
for biophysical methods, such as X-ray crystallography and NMR. However, cryo-
electron microscopic analysis differs from these techniques in that it can be used to study
membrane proteins in a crystalline or non-crystalline state at high resolution [17]. This
6
11
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123124
125
126
127
128
129
12
![Page 7: Membrane proteins and drug discovery: what is the linkhomes.gersteinlab.org/.../Drug_Discovery_Review_Arinami… · Web view[1] Davey, J. (2004) G-Protein-Coupled-Receptors: New](https://reader035.vdocument.in/reader035/viewer/2022070806/5f0499097e708231d40ec2e4/html5/thumbnails/7.jpg)
Drug Discovery Today: Informatics (Computational Drug Discovery)
has enabled, for example, the structure of bacteriorhodopsin to be analyzed to a resolution
of 2.8Å [18], [19]. Thirdly, membrane proteins are generally insoluble in aqueous
solution hence detergents are required in concentrations above the critical micellar
concentration (CMC). Too much detergent can denature the protein or impede
crystallization by phase separation, whilst too little and the protein may become
insoluble. The production of three-dimensional (3D) or two-dimensional (2D) crystals
remains one of the major challenges in obtaining structural information.
Despite the inherent difficulties in studying the structure of membrane proteins,
they remain a crucial area of study due to their essential role in the control of important
biochemical processes. A number of experimental methods exist and are continually
being developed with the aid of technological tools to extract structural information on
membrane proteins. Spectroscopic methods [20], [21] such as vibrational spectroscopy,
Raman, FTIR and circular dichroism (CD) have been utilized to determine their
secondary structure and to help distinguish between competing models of structure or
function. Bacteriorhodopsin [22], the acetylcholine receptor [23], lactose permease [24]
and the outer membrane proteins of E. coli [25] are examples of membrane proteins
whose secondary structure content have been determined with such techniques.
Alternative methods, namely crystallographic techniques, have since been used to
determine high-resolution structures. Three methods are generally employed: electron
microscopy, NMR and X-ray crystallography. Despite the difficulties involved in
generating large and sufficiently well-ordered 3D crystals, X-ray crystallography is still
the most successful and least difficult technique for obtaining high-resolution structures.
Electron crystallography [26] and atomic force microscopy (AFM) [27], [28] are also
7
13
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
14
![Page 8: Membrane proteins and drug discovery: what is the linkhomes.gersteinlab.org/.../Drug_Discovery_Review_Arinami… · Web view[1] Davey, J. (2004) G-Protein-Coupled-Receptors: New](https://reader035.vdocument.in/reader035/viewer/2022070806/5f0499097e708231d40ec2e4/html5/thumbnails/8.jpg)
Drug Discovery Today: Informatics (Computational Drug Discovery)
used as methods for membrane proteins whose natural propensity is to form 2D arrays
[29].
Each method has its own advantages and hence the structural data obtained are
complementary. All methods are generally used in parallel in an attempt to achieve the
best structural description of a membrane protein. In addition, methods are continually
being developed, with the use of computational resources, leading to an increasing rate of
membrane protein structure determination. From the plot [Figure 3], the growth of known
structures is exponential with a growth rate of ~1.3-fold per year, but lags behind the rate
for soluble proteins during the equivalent time period. Assuming a continuous
exponential rate of growth in the number of structures determined, we would expect close
to 300 structures to be known by the end of 2008. Despite the increasing rate of structure
determination, improved structure prediction methods combined with computational tools
are important in studying membrane proteins.
8
0
0.5
1
1.5
2
2.5
3
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007
Year
Log
(cum
ulat
ive
num
ber o
f str
uctu
res)
15
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
16
![Page 9: Membrane proteins and drug discovery: what is the linkhomes.gersteinlab.org/.../Drug_Discovery_Review_Arinami… · Web view[1] Davey, J. (2004) G-Protein-Coupled-Receptors: New](https://reader035.vdocument.in/reader035/viewer/2022070806/5f0499097e708231d40ec2e4/html5/thumbnails/9.jpg)
Drug Discovery Today: Informatics (Computational Drug Discovery)
1.4 Computational Structure Determination
Computer simulation methods have provided key insights into the general nature
of protein motion and aspects of motion linked to the function of proteins in their native
state. They are rapidly becoming a standard tool to study the structure and dynamics of
membrane proteins. With the increasing number of high-resolution structures of
membrane proteins, a wide range of membrane proteins can now be simulated over time
spans that capture essential biological processes. Whilst X-ray structures of membrane
proteins provide static, spatially and temporally averaged snapshots of the proteins in
specific crystal environments, simulations enable us to explore the structural dynamics of
the proteins in an attempt to bridge the gap between structure and function of proteins. By
employing computational methods one can combine both experimental and theoretical
data of ion channels in order to describe their physiological properties in terms of
underlying physical processes.
One of the main challenges is to relate molecular structures to the physiological
properties of the protein. For ion channels this has been addressed by describing the
structure of the channel at varying levels of detail and accuracy, where the key regions
can be broken down into the transbilayer pore, the selectivity filter and the gate. A wide
variety of computational approaches such as molecular dynamics (MD) simulations (e.g.
[30], [31], [32]), continuum electrostatic Poisson-Boltzmann (PB) theory [33], [34],
Brownian dynamics (BD) [35], [36], electrodiffusion theory [37] have helped to refine
our understanding of the molecular determinants of channel function. MD arguably
provides the most detailed information in the theoretical studies of membrane proteins.
9
17
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
18
![Page 10: Membrane proteins and drug discovery: what is the linkhomes.gersteinlab.org/.../Drug_Discovery_Review_Arinami… · Web view[1] Davey, J. (2004) G-Protein-Coupled-Receptors: New](https://reader035.vdocument.in/reader035/viewer/2022070806/5f0499097e708231d40ec2e4/html5/thumbnails/10.jpg)
Drug Discovery Today: Informatics (Computational Drug Discovery)
In an MD simulation, all atoms in the system (including ions and water
molecules) are represented explicitly. In the classical fine-grained approach, simulations
are typically carried out using empirically determined pairwise interaction potentials
between the atoms. Another MD approach, known as ab initio MD, uses interactions
between atoms determined from first principles electronic structure calculations. Since
there are no free parameters with this approach, it could potentially be the ideal approach
to modeling ion channels. However, due to the extremely demanding nature of the
computations, its applications are currently limited to very small systems.
With the atomistic approach of classical MD simulations, rapid advances in
simulation methodologies and computational power has led to accessible timescales of up
to 0.1 s. Amongst all structurally known membrane proteins, the ion channels (KvAP,
KcsA), transporters (AQP, GlpF, ABC transporter), and outer membrane proteins
(OmpA) have been examined via simulation in particular detail. The methods described
will be briefly compared using the bacterial K+ channel, KcsA, as a case study. This is the
first biological ion channel whose tertiary structure was elucidated [38] and has been
studied extensively in terms of ion selectivity, permeation and gating.
1.5 Comparisons between MD techniques
MD simulations on KcsA have been employed to examine channel selectivity, ion
permeation and ion transport energetics in potassium channels, with the main focus being
on the selectivity filter and understanding the permeation properties of K+ ions in the
filter and cavity region. Many of the results from MD simulations based on realistic all-
10
19
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
20
![Page 11: Membrane proteins and drug discovery: what is the linkhomes.gersteinlab.org/.../Drug_Discovery_Review_Arinami… · Web view[1] Davey, J. (2004) G-Protein-Coupled-Receptors: New](https://reader035.vdocument.in/reader035/viewer/2022070806/5f0499097e708231d40ec2e4/html5/thumbnails/11.jpg)
Drug Discovery Today: Informatics (Computational Drug Discovery)
atom models have been consistent with the information obtained from high-resolution
structural data [39].
The scope of MD simulations can be extended by using commonly utilized
algorithms. For example, three methods employed are (i) umbrella sampling [40]; (ii) the
application of external forces to the system, such as using an expanding sphere inside the
pore at the gate region of the KcsA channel to induce gating [41], and with the
application of steered-MD; (iii) alchemical free energy perturbation (FEP) [42][43].
Although results from these techniques increase our confidence in MD, we cannot build a
complete picture of ion permeation if ion fluxes cannot be simulated or if channel
conductance cannot be calculated. Single-channel measurements reveal the net
translocation of one ion in KcsA to be in 10-20 ns [44] which is the order of timescales
accessible by MD simulations [42][45]).
Despite the significant increase in computational power and molecular dynamics
methods, the direct simulation of ionic fluxes across channels and large conformational
changes using an atomistic description remains computationally challenging at present.
This is due to time scales of 10 – 100 ns being much shorter than the typical timescale for
allosteric effects which is usually in the order of microseconds to milliseconds. Thus,
biased MD methods, such as steered MD (e.g. [46]) and targeted MD (e.g. [47]) have
been developed to circumvent these time scale limitations. However, the above described
weakness of MD is the strength of Brownian Dynamics (BD). The drawback of BD is,
however, the comparatively poor description or parameterization of the biological system
simulated. Thus, diffusion coefficients and free energies for example, which can be
11
21
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
22
![Page 12: Membrane proteins and drug discovery: what is the linkhomes.gersteinlab.org/.../Drug_Discovery_Review_Arinami… · Web view[1] Davey, J. (2004) G-Protein-Coupled-Receptors: New](https://reader035.vdocument.in/reader035/viewer/2022070806/5f0499097e708231d40ec2e4/html5/thumbnails/12.jpg)
Drug Discovery Today: Informatics (Computational Drug Discovery)
determined with MD, cannot be calculated with BD. Hence, both BD and MD are
complementary.
In BD, ion permeation can be simulated for sufficiently long to measure channel
conductance without having to treat a system in all atomic details explicitly. BD
simulations (for example on KcsA [48] [49]) treat protein atoms forming the channel as
rigid, and the water implicitly as a dielectric continuum performing Brownian motion.
Despite these severe limitations of the continuum electrostatic approximation and the
assumption of a rigid channel structure, BD simulations [50] confirmed the multi-ion
mechanism to be in agreement with the ion flux determined experimentally [51]. The
ability to compute current flow across ion channels confers a distinct advantage to BD
simulations over other techniques with the applications of BD to calculating current and
voltage conductance in ion channels. The assumptions in BD of treating the water-protein
interface as a rigid boundary and the treatment of water in a narrow pore as a continuum
are simplifications since proteins (and lipid bilayers) are in fact dynamical, undergoing
fluctuations on a picosecond timescale, which is much more rapid that the timescale for
ion permeation.
The treatment of the water-protein boundary has been modified in some studies in
an attempt to reduce its simplified stochastic nature. For example, an elaborate treatment
of boundaries was proposed [52][53] using a grand canonical Monte Carlo (GCMC)
method. However, comparison of BD using a simple stochastic boundary and the GCMC
boundary [54] revealed no significant differences with the results obtained when the
boundaries were at a reasonable distance from the channel. MD is also the preferred
12
23
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
24
![Page 13: Membrane proteins and drug discovery: what is the linkhomes.gersteinlab.org/.../Drug_Discovery_Review_Arinami… · Web view[1] Davey, J. (2004) G-Protein-Coupled-Receptors: New](https://reader035.vdocument.in/reader035/viewer/2022070806/5f0499097e708231d40ec2e4/html5/thumbnails/13.jpg)
Drug Discovery Today: Informatics (Computational Drug Discovery)
technique for size-dependent selectivity among ions with the same valence, since such
ions cannot be distinguished in BD. Whilst microscopic quantities can be deduced from
BD, the increased high-level detail adopted by MD and Monte Carlo (MC) algorithms
enables the analysis of large-scale conformational changes. For example, one study [55]
explored the conformational changes between the open (KcsA crystal structure [38] and
closed forms (model generated from MthK [56]) of KcsA. The simulation of the large-
scale conformational transition was run by imposing lateral forces to the C-termini of the
inner helices and minimizing the energy at each step. As a result of the applied forces the
inner helices converged to form a tightly packed structure, with a change in backbone
geometry in the central region.
Whilst MD provides the most detailed information about the dynamics of ion
channels, currently accessible simulation times are its greatest limitation. Hence it is
unclear at present if the results obtained from MD simulations reflect reality or are an
artifact of the method. However, this problem seems sure to be surmounted in the future
with the doubling of computer speeds over the years. In the meantime faster, more
coarse-grained methods are being employed [57][58] to calculate the conductance of ion
channels. In addition, free energy methods such as replica exchange and ensemble
dynamics [59][60] are methods that are becoming increasingly viable with increasing
computational power. Despite such hurdles, MD simulations in combination with other
computational tools such as homology modelling, and experimental studies such as
mutagenesis analysis, have proved to be essential in the study of membrane protein
structure and function, which in turn enables the development of novel pharmacological
drug targets.
13
25
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
26
![Page 14: Membrane proteins and drug discovery: what is the linkhomes.gersteinlab.org/.../Drug_Discovery_Review_Arinami… · Web view[1] Davey, J. (2004) G-Protein-Coupled-Receptors: New](https://reader035.vdocument.in/reader035/viewer/2022070806/5f0499097e708231d40ec2e4/html5/thumbnails/14.jpg)
Drug Discovery Today: Informatics (Computational Drug Discovery)
1.6 Conclusions and Future Outlooks
Integral membrane proteins (IMPs) perform key functions in regulating the
physiological state of the cell. This is especially true for receptors and ion channels that
control, for example, the transmembrane (TM) potential. The scarcity of IMP structures is
due to the fact that the route from membrane protein sequences to atomic-resolution
structures is not as straightforward as for their soluble counterparts. This is, in turn,
primarily due to the substantial difficulties with overexpression and crystallization of
IMPs. Thus, the use of computational tools such as protein simulation methods, in
combination with experimental and structural genomic studies is becoming increasingly
valuable in studying the structure and function of membrane proteins.
The explosion of genomic data in combination with huge advances in
computational resources and experimental techniques is leading to a greater
understanding of biological structure, function and mechanisms. Considering the
dramatic advancements in molecular dynamics simulation methodologies in recent years,
it is likely that current drawbacks will be overcome considerably in the near future.
Reassuringly, over the last few years there has been a dramatic increase in the number of
membrane protein crystal structures obtained, with 30 structures being solved in 2006
alone.
Unsurprisingly, given the immense computing power and wealth of genomic and
structural data, recent years have seen a rise in structural genomics initiatives primarily
focusing on membrane proteins in an attempt to harness the synergy between the growing
data and technology available. Examples of such initiatives include the (1) Swiss
14
27
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
28
![Page 15: Membrane proteins and drug discovery: what is the linkhomes.gersteinlab.org/.../Drug_Discovery_Review_Arinami… · Web view[1] Davey, J. (2004) G-Protein-Coupled-Receptors: New](https://reader035.vdocument.in/reader035/viewer/2022070806/5f0499097e708231d40ec2e4/html5/thumbnails/15.jpg)
Drug Discovery Today: Informatics (Computational Drug Discovery)
National Center of Competence in Research (NCCR; www.structralbiology.ethz.ch), (2)
Membrane Protein Network (MePNet; www.mepnet.org), (3) European Membrane
Proteins (E-MeP; www.e-mep.org), (4) Protein Wide Analysis of Membrane Proteins
(ProAMP; www.pst-ag.com), (5) Biological Information Research Center, Japan (BRIC;
unit.aist.go.jp/birc) and the (6) Membrane Protein Structure Initiative (MPSI;
www.mpsi.ac.uk). At present, the large majority of crystallized membrane proteins are
bacterial proteins, thus there is an urgent need to obtain structures of eukaryotic
membrane proteins as these could be potential drug targets. In this respect, structural
genomics initiatives are essential for rapidly increasing the structure determination
throughput of eukaryotic membrane proteins. Interestingly, this situation is analogous to
that of soluble proteins; slow structure determination in the 1970s was followed by an
exponential increase of structures generated due to improved experimental protocols.
The paradox posed by the sheer number of potential helical membrane proteins
and the lack of high-resolution structural and thermodynamic information for them
emphasizes the extensive work that remains to be done in the field of membrane proteins.
The potential payoff may be great as this class of proteins has historically contained
excellent targets for therapeutics. Advances in our ability to understand and manipulate
membrane proteins may lead to the discovery or design or pharmaceutical agents that can
modulate their functions.
15
29
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
30
![Page 16: Membrane proteins and drug discovery: what is the linkhomes.gersteinlab.org/.../Drug_Discovery_Review_Arinami… · Web view[1] Davey, J. (2004) G-Protein-Coupled-Receptors: New](https://reader035.vdocument.in/reader035/viewer/2022070806/5f0499097e708231d40ec2e4/html5/thumbnails/16.jpg)
Drug Discovery Today: Informatics (Computational Drug Discovery)
References
[1] Davey, J. (2004) G-Protein-Coupled-Receptors: New Approaches to Maximize the Impact of GPCRs in Drug Discovery. Expert Opinion on Therapeutic Targets 8, 165-170.
[2] Terstappen, G. C., and Reggiani, A. (2001) In silico research in drug discovery. Trends Pharmacol. Sci. 22, 23-26.
[3] Xia, Y. et al. (2006) Integrated prediction of the helical membrane protein interactome in yeast. J. Mol. Biol. 357, 339-349.
[4] Hurwitz, N. et al. (2006) Towards genome-scale structure prediction for transmembrane proteins. Phil. Trans. Roy. Soc. ser. B 361, 465-475.
[5] Lundstrom, K. (2005) Structural Genomics of GPCRs. Trends Biotech. 23, 103-108.
[6] Walian, P. et al. (2004) Structural Genomics of Membrane Proteins. (2004) Genome Biol. 5, 215.
[7] Lehnert, U. et al. (2004) Computational analysis of membrane proteins: genomic occurrence, structure prediction and helix interactions. Q. Rev. Biophys. 37, 121-146.
[8] Sachs, J.N. and Engelman, D.M. (2006) Introduction to Membrane Protein Reviews: Interplay between Structure, Dynamics, and Environment in Membrane Protein Function. Annu. Rev. Biochem. 75, 707-712.
[9] Engelman, D.M. et al. (2003) Membrane Protein Folding: Beyond the Two Stage Model. (2003) Febbs Lett. 555, 122-125.
[10] Cowan, S. W., and Rosenbusch, J. P. (1994) Folding pattern diversity of integral membrane-proteins. Science 264, 914-916.
[11] Pautsch, A., and Schulz, G. E. (1998) Structure of the outer membrane protein A transmembrane domain. Nature Struct. Biol. 5, 1013-1017.
[12] Ferguson, A. D. et al. (2002) Structural basis of gating by the outer membrane transporter FecA. Science 295, 1715-1719.
[13] Grisshammer, R., and Tate, C. G. (1995) Overexpression of integral membrane-proteins for structural studies. Q. Rev. Biophys. 28, 315-422.
16
31
329
330331332333334335
336337
338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368
32
![Page 17: Membrane proteins and drug discovery: what is the linkhomes.gersteinlab.org/.../Drug_Discovery_Review_Arinami… · Web view[1] Davey, J. (2004) G-Protein-Coupled-Receptors: New](https://reader035.vdocument.in/reader035/viewer/2022070806/5f0499097e708231d40ec2e4/html5/thumbnails/17.jpg)
Drug Discovery Today: Informatics (Computational Drug Discovery)
[14] Buchanan, S. K. (1999) ß-Barrel proteins from bacterial outer membranes: structure, function and refolding. Curr. Opin. Struct. Biol. 9, 455-461.
[15] Schulz, G. E. (2000) -Barrel membrane proteins. Curr. Opin. Struct. Biol. 10, 443-447.
[16] Tate, C. G. (2001) Overexpression of mammalian integral membrane proteins for structural studies. FEBS Lett. 504, 94-98.
[17] Chiu, W. (1993) What does electron cryomicroscopy provide that X-ray crystallography and NMR spectroscopy cannot? Ann. Rev. Biophys. Biomol. Struct. 22, 233-355.
[18] Baldwin, J. M., Henderson, R., Beckmann, E., & Zemlin, F. (1998) Images of purple membrane at 2.8Å resolution obtained by cryo-electron microscopy. J. Mol. Biol. 202, 585-591.
[19] Fujiyoshi, Y. (1998) The structural study of membrane proteins by electron crystallography. Adv. Biophys. 35, 25-80.
[20] Bazzi, M. and Woody, R. W. (1985) Oriented secondary structure in integral membrane proteins. Biophys. J. 48, 957-966.
[21] Krimm, S. and Bandekar, J. (1986) Vibrational spectroscopy and conformation of peptides, polypeptides and proteins. Adv. Protein Chem. 38, 183-364.
[22] Glaeser, R. M. et al. (1991) What spectroscopy can still tell us about the secondary structure of bacteriorhodopsin. Biophys. J. 59, 934-938.
[24] Yager, P. et al. (1984) The secondary structure of acetylcholine receptor reconstituted in a single lipid component as determined by Raman spectroscopy. Biophys. J. 45, 26-28.
[25] Vogel, H. et al. (1985) The structure of the lactose permease derived from Raman spectroscopy and prediction methods. EMBO J. 4, 3625-3631.
[25] Vogel, H. and Jähnig, E. (1986) Models for the structure of outer-membrane proteins of Escherichia coli derived from raman spectroscopy and prediction methods. J. Mol. Biol. 190, 191-199.
[26] Saibil, H. R. (2000) Conformational changes studied by cryo-electron microscopy. Nature 7, 711-717.
[27] Clausen-Schaumann, et al. (2000) Force spectroscopy with single bio-molecules. Curr. Opin. Chem. Biol. 4, 524-530.
17
33
369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414
34
![Page 18: Membrane proteins and drug discovery: what is the linkhomes.gersteinlab.org/.../Drug_Discovery_Review_Arinami… · Web view[1] Davey, J. (2004) G-Protein-Coupled-Receptors: New](https://reader035.vdocument.in/reader035/viewer/2022070806/5f0499097e708231d40ec2e4/html5/thumbnails/18.jpg)
Drug Discovery Today: Informatics (Computational Drug Discovery)
[28] Scheuring, S. et al. (2002) Sampling the conformational space of membrane protein surfaces with the AFM. Eur. Biophys. J. 31, 172-178.
[29] Stahlberg, H. et al. (2001) Two-dimensional crystals: a powerful approach to assess structure, function and dynamics of membrane proteins. FEBS Lett. 504, 166-172.
[30] Sotomayor, M., Vasquez, V., Perozo, E. & Schulten, K. (2007) Ion Conduction through MscS as Determined by Electrophysiology and Simulation. Biophys. J. 92, 886-902.
[31] Saparov, S.M. et al. (2007) Fast and Selective Ammonia Transport by Aquaporin-8. J. Biol. Chem. 282, 5296-5301.
[32] Mukherjee, P. et al. (2006) Picosecond dynamics of a membrane protein revealed by 2D IR. Proc. Natl. Acad. Sci. U.S.A. 103, 3528-3533.
[33] Peter, C. and Hummer, G. (2005) Ion Transport through Membrane-Spanning Nanopores Studied by Molecular Dynamics Simulations and Continuum Electrostatics Calculations Biophys. J. 89, 2222-2234.
[34] Sengupta, D. et al. (2005) Understanding the energetics of helical peptide orientation in membranes. Proteins 58, 913-922.
[35] Sieber, J.J. et al. (2007) Anatomy and Dynamics of a Supramolecular Membrane Protein Cluster. Science 317, 1072-1076
[36] Jin, S. et al. (2007) Single-Particle Tracking of Membrane Protein Diffusion in a Potential: Simulation, Detection, and Application to Confined Diffusion of CFTR Cl– Channels. Biophys. J. 93, 1079-1088.
[37] Coalson, R.D. (2005) Poisson-Nernst-Plank Theory approach to the calculation of current through biological ion channels. Nanobiosci. 4, 81-93.
[38] Doyle, D. A. et al. (1998) The structure of the potassium channel: molecular basis of K+ conduction and selectivity. Science 280, 69-77.
[39] Roux, B. (2002) Theoretical and computational models of ion channels. Curr. Opin. Struct. Biol. 12, 182-189.
[40] Crouzy, S. et al. (2001) Extracellular blockade of K+ channels by TEA: Results from molecular dynamics simulations of the KcsA channel. J. Gen. Physiol. 118, 207-217.
[41] Biggin, P. C. and Sansom, M. S. P. (2002) Open-state models of a potassium channel. Biophys. J. 83, 1867-1876.
18
35
415416417418
419420421
422423
424425
426427428
429430
431432433434435436437438439440441442443444445446447448449450451452453
36
![Page 19: Membrane proteins and drug discovery: what is the linkhomes.gersteinlab.org/.../Drug_Discovery_Review_Arinami… · Web view[1] Davey, J. (2004) G-Protein-Coupled-Receptors: New](https://reader035.vdocument.in/reader035/viewer/2022070806/5f0499097e708231d40ec2e4/html5/thumbnails/19.jpg)
Drug Discovery Today: Informatics (Computational Drug Discovery)
[42] Åqvist, J. and Luzhkov, V. (2000) Ion permeation mechanism of the potassium channel. Nature 404, 881-884.
[43] Berneche, S. and Roux, B. (2002) The Ionization State and the Conformation of Glu-71 in the KcsA Channel. Biophys. J. 82, 772-780.
[44] LeMasurier, M. et al. (2001) KcsA: It's a potassium channel. J. Gen. Physiol. 118, 303-313.
[45] Domene, C. and Sansom, M. S. P. (2003) Potassium channel, ions and water: simulation studies based on the high-resolution X-ray structure of KcsA. Biophys. J. 85, 2787-2800.
[46] Treptow, W. and Tarek, M. (2006) K+ conduction in the selectivity filter of potassium channels is monitored by the charge distribution along their sequence. Biochem. 91, L81-L83.
[47] Compoint, P. et al. (2006) Targeted Molecular Dynamics of an open-state KcsA channel. J. Chem. Phys. 13, 134707.
[48] Allen, T. W. and Chung, S. H. (2001) Brownian dynamics study of an open-state KcsA potassium channel. Biochim. Biophys. Acta. 1515, 83-91.
[49] Burykin, A. et al. (2003) Exploring the origin of the ion selectivity of the KcsA potassium channel. Proteins: Structure Function and Genetics 52, 412-426.
[50] Chung, S. H. et al. (2002) Conducting-state properties of the KcsA potassium channel from molecular and Brownian dynamics simulations. Biophys. J. 82, 628-645.
[51] Ermak, D. L. and McCammon, J. A. (1978) Brownian dynamics with hydrodynamic interactions. J. Chem. Phys., 69, 1352-1360.
[52] Im, W. et al (2000) A Grand Canonical Monte Carlo-Brownian dynamics algorithm for simulating ion channels. Biophys. J. 79, 788-801.
[53] Woo, H.-J. et al. (2004) Grand canonical Monte Carlo simulations of water in protein environments. J. Chem. Phys. 121, 6392-6982.
[54] Corry, B. et al. (2002) Reservoir Boundaries in Brownian Dynamics Simulations of Ion Channels. Biophys. J. 82, 1975-1984.
[55] Tikhonov, D. B. and Zhorov, B. S. (2004) In Silico Activation of KcsA K+ channel by Lateral Forces Applied to the C-termini of Inner Helices. Biophys. J. 87, 1526-1536.
19
37
454455456457458459460461462463464465466467468469470471472473474475476477478479480481482483484485486487488489490491492493494495496497498499
38
![Page 20: Membrane proteins and drug discovery: what is the linkhomes.gersteinlab.org/.../Drug_Discovery_Review_Arinami… · Web view[1] Davey, J. (2004) G-Protein-Coupled-Receptors: New](https://reader035.vdocument.in/reader035/viewer/2022070806/5f0499097e708231d40ec2e4/html5/thumbnails/20.jpg)
Drug Discovery Today: Informatics (Computational Drug Discovery)
[56] Jiang, Y., et al. (2002) The open pore conformation of potassium channels. Nature 417, 523-526.
[57] Brannigan, G. et al. (2007) Implicit solvent simulation models for biomembranes. Eur. Biophys. J. 35, 104-124.
[58] Lei, H. and Duan, Y. (2007) Improved sampling methods for molecular simulation. Curr. Opin. Struct. Biol. 17, 187-191.
[59] Bu, L. et al. Membrane Assembly of Simple Helix Homo-Oligomers studied via molecular dynamics simulations. Biophys. J. 92, 854-863.
[60] Chen, Z. and Xu, Y. (2006) Energetics and stability of transmembrane helix packing: A replica-exchange simulation with a knowledge-based membrane potential. Proteins: Structure Function and Genetics 62, 539-552
20
39
500501502503504505506507508509510511512513514
40
![Page 21: Membrane proteins and drug discovery: what is the linkhomes.gersteinlab.org/.../Drug_Discovery_Review_Arinami… · Web view[1] Davey, J. (2004) G-Protein-Coupled-Receptors: New](https://reader035.vdocument.in/reader035/viewer/2022070806/5f0499097e708231d40ec2e4/html5/thumbnails/21.jpg)
Drug Discovery Today: Informatics (Computational Drug Discovery)
Figure Legends
Figure 1: Two examples of membrane proteins. KcsA (left) (PDB: 1K4C) is a voltage-
gated K+ selective α-helical protein. OmpA (right) (PDB: 1QJP) is an example of a β-
barrel membrane protein. The dashed lines indicate the position of the bilayer.
Figure 2: Illustration of a membrane protein (KcsA, shown in purple) embedded in a lipid
bilayer. For clarity, the water molecules on either side of the lipid bilayer have not been
included. The hydrocarbon core of a membrane is typically ~25-30Å wide with the
headgroups spanning ~10Å. The polar head groups of the lipids face the aqueous
environment on both sides of the membrane, whereas their hydrophobic chains form the
insulating interior of the bilayer. Owing to the ester carbonyls and water associated to the
lipid headgroups, lipid molecules possess electrical dipoles which result in a considerable
electrical potential (positive inside the bilayer). (Figure generated using KcsA crystal
structure, PDB: 1K4C).
Figure 3: Rate at which new structures (α-helical and β-barrel) have been determined
since 1991. The count of membrane protein structures includes the same protein from
different organisms. The data suggests that there will be ~300 structures at the end of
2008. Data extracted from http://blanco.biomol.uci.edu/Membrane_Proteins_xtal.html
21
41
515516517
518
519
520521522
523
524
525
526
527
528
529
530
531532533
534
535
536
537
42